nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.12	0.216	CbGbCtD
Oxymorphone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0911	0.164	CbGbCtD
Oxymorphone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0782	0.14	CbGbCtD
Oxymorphone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0771	0.139	CbGbCtD
Oxymorphone—CYP3A4—Prednisone—ankylosing spondylitis	0.0729	0.131	CbGbCtD
Oxymorphone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0715	0.129	CbGbCtD
Oxymorphone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0455	0.0817	CbGbCtD
Oxymorphone—Naloxone—TLR4—ankylosing spondylitis	0.0272	1	CrCbGaD
Oxymorphone—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00172	0.00414	CcSEcCtD
Oxymorphone—Abdominal distension—Prednisone—ankylosing spondylitis	0.0017	0.00408	CcSEcCtD
Oxymorphone—Hallucination—Methylprednisolone—ankylosing spondylitis	0.0017	0.00408	CcSEcCtD
Oxymorphone—Lethargy—Methotrexate—ankylosing spondylitis	0.00167	0.004	CcSEcCtD
Oxymorphone—Sweating increased—Prednisone—ankylosing spondylitis	0.00164	0.00395	CcSEcCtD
Oxymorphone—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00164	0.00395	CcSEcCtD
Oxymorphone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00159	0.00383	CcSEcCtD
Oxymorphone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00158	0.0038	CcSEcCtD
Oxymorphone—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00158	0.0038	CcSEcCtD
Oxymorphone—Bradycardia—Betamethasone—ankylosing spondylitis	0.00158	0.0038	CcSEcCtD
Oxymorphone—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00155	0.00372	CcSEcCtD
Oxymorphone—Hallucination—Dexamethasone—ankylosing spondylitis	0.00154	0.00371	CcSEcCtD
Oxymorphone—Hallucination—Betamethasone—ankylosing spondylitis	0.00154	0.00371	CcSEcCtD
Oxymorphone—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00154	0.0037	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00154	0.00369	CcSEcCtD
Oxymorphone—Weight decreased—Prednisone—ankylosing spondylitis	0.00153	0.00367	CcSEcCtD
Oxymorphone—Vision blurred—Prednisolone—ankylosing spondylitis	0.00153	0.00367	CcSEcCtD
Oxymorphone—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0015	0.00359	CcSEcCtD
Oxymorphone—Visual impairment—Betamethasone—ankylosing spondylitis	0.0015	0.00359	CcSEcCtD
Oxymorphone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00149	0.00359	CcSEcCtD
Oxymorphone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00149	0.00357	CcSEcCtD
Oxymorphone—Vertigo—Prednisolone—ankylosing spondylitis	0.00145	0.00349	CcSEcCtD
Oxymorphone—Syncope—Prednisolone—ankylosing spondylitis	0.00145	0.00349	CcSEcCtD
Oxymorphone—Eye disorder—Betamethasone—ankylosing spondylitis	0.00145	0.00348	CcSEcCtD
Oxymorphone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00145	0.00348	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00142	0.00342	CcSEcCtD
Oxymorphone—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00141	0.00338	CcSEcCtD
Oxymorphone—Angiopathy—Betamethasone—ankylosing spondylitis	0.00141	0.00338	CcSEcCtD
Oxymorphone—Convulsion—Prednisolone—ankylosing spondylitis	0.0014	0.00337	CcSEcCtD
Oxymorphone—Hypertension—Prednisolone—ankylosing spondylitis	0.0014	0.00336	CcSEcCtD
Oxymorphone—Bradycardia—Prednisone—ankylosing spondylitis	0.00138	0.00331	CcSEcCtD
Oxymorphone—Hallucination—Prednisone—ankylosing spondylitis	0.00134	0.00323	CcSEcCtD
Oxymorphone—Vertigo—Triamcinolone—ankylosing spondylitis	0.00134	0.00321	CcSEcCtD
Oxymorphone—Syncope—Triamcinolone—ankylosing spondylitis	0.00134	0.00321	CcSEcCtD
Oxymorphone—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00133	0.00321	CcSEcCtD
Oxymorphone—Syncope—Methylprednisolone—ankylosing spondylitis	0.00133	0.0032	CcSEcCtD
Oxymorphone—Oedema—Prednisolone—ankylosing spondylitis	0.00132	0.00317	CcSEcCtD
Oxymorphone—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00131	0.00314	CcSEcCtD
Oxymorphone—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00131	0.00314	CcSEcCtD
Oxymorphone—Shock—Prednisolone—ankylosing spondylitis	0.0013	0.00312	CcSEcCtD
Oxymorphone—Convulsion—Triamcinolone—ankylosing spondylitis	0.00129	0.0031	CcSEcCtD
Oxymorphone—Tachycardia—Prednisolone—ankylosing spondylitis	0.00129	0.0031	CcSEcCtD
Oxymorphone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00129	0.00309	CcSEcCtD
Oxymorphone—Hypertension—Triamcinolone—ankylosing spondylitis	0.00129	0.00309	CcSEcCtD
Oxymorphone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00128	0.00308	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00128	0.00307	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—ankylosing spondylitis	0.00127	0.00304	CcSEcCtD
Oxymorphone—Eye disorder—Prednisone—ankylosing spondylitis	0.00126	0.00303	CcSEcCtD
Oxymorphone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00126	0.00303	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00126	0.00302	CcSEcCtD
Oxymorphone—Flushing—Prednisone—ankylosing spondylitis	0.00125	0.00301	CcSEcCtD
Oxymorphone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00124	0.00298	CcSEcCtD
Oxymorphone—Angiopathy—Prednisone—ankylosing spondylitis	0.00123	0.00295	CcSEcCtD
Oxymorphone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00122	0.00294	CcSEcCtD
Oxymorphone—Immune system disorder—Prednisone—ankylosing spondylitis	0.00122	0.00293	CcSEcCtD
Oxymorphone—Oedema—Triamcinolone—ankylosing spondylitis	0.00121	0.00292	CcSEcCtD
Oxymorphone—Vertigo—Dexamethasone—ankylosing spondylitis	0.00121	0.00292	CcSEcCtD
Oxymorphone—Vertigo—Betamethasone—ankylosing spondylitis	0.00121	0.00292	CcSEcCtD
Oxymorphone—Syncope—Betamethasone—ankylosing spondylitis	0.00121	0.00291	CcSEcCtD
Oxymorphone—Syncope—Dexamethasone—ankylosing spondylitis	0.00121	0.00291	CcSEcCtD
Oxymorphone—Shock—Triamcinolone—ankylosing spondylitis	0.0012	0.00287	CcSEcCtD
Oxymorphone—Insomnia—Prednisolone—ankylosing spondylitis	0.00119	0.00287	CcSEcCtD
Oxymorphone—Shock—Methylprednisolone—ankylosing spondylitis	0.00119	0.00287	CcSEcCtD
Oxymorphone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00119	0.00286	CcSEcCtD
Oxymorphone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00119	0.00285	CcSEcCtD
Oxymorphone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00119	0.00285	CcSEcCtD
Oxymorphone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00119	0.00285	CcSEcCtD
Oxymorphone—Mental disorder—Prednisone—ankylosing spondylitis	0.00118	0.00284	CcSEcCtD
Oxymorphone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00118	0.00284	CcSEcCtD
Oxymorphone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00118	0.00283	CcSEcCtD
Oxymorphone—Malnutrition—Prednisone—ankylosing spondylitis	0.00118	0.00283	CcSEcCtD
Oxymorphone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00117	0.00282	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00117	0.00282	CcSEcCtD
Oxymorphone—Convulsion—Dexamethasone—ankylosing spondylitis	0.00117	0.00281	CcSEcCtD
Oxymorphone—Convulsion—Betamethasone—ankylosing spondylitis	0.00117	0.00281	CcSEcCtD
Oxymorphone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00117	0.0028	CcSEcCtD
Oxymorphone—Hypertension—Betamethasone—ankylosing spondylitis	0.00117	0.0028	CcSEcCtD
Oxymorphone—Anxiety—Dexamethasone—ankylosing spondylitis	0.00115	0.00275	CcSEcCtD
Oxymorphone—Anxiety—Betamethasone—ankylosing spondylitis	0.00115	0.00275	CcSEcCtD
Oxymorphone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00113	0.00272	CcSEcCtD
Oxymorphone—Pain—Prednisolone—ankylosing spondylitis	0.00113	0.00271	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00112	0.00268	CcSEcCtD
Oxymorphone—Vision blurred—Prednisone—ankylosing spondylitis	0.00111	0.00266	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00266	CcSEcCtD
Oxymorphone—Oedema—Betamethasone—ankylosing spondylitis	0.0011	0.00265	CcSEcCtD
Oxymorphone—Oedema—Dexamethasone—ankylosing spondylitis	0.0011	0.00265	CcSEcCtD
Oxymorphone—Insomnia—Triamcinolone—ankylosing spondylitis	0.0011	0.00264	CcSEcCtD
Oxymorphone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0011	0.00263	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00109	0.00262	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—ankylosing spondylitis	0.00109	0.00261	CcSEcCtD
Oxymorphone—Shock—Betamethasone—ankylosing spondylitis	0.00108	0.00261	CcSEcCtD
Oxymorphone—Shock—Dexamethasone—ankylosing spondylitis	0.00108	0.00261	CcSEcCtD
Oxymorphone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00108	0.0026	CcSEcCtD
Oxymorphone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00108	0.0026	CcSEcCtD
Oxymorphone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00108	0.0026	CcSEcCtD
Oxymorphone—Agitation—Prednisone—ankylosing spondylitis	0.00108	0.0026	CcSEcCtD
Oxymorphone—Tachycardia—Betamethasone—ankylosing spondylitis	0.00108	0.00259	CcSEcCtD
Oxymorphone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00108	0.00259	CcSEcCtD
Oxymorphone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00107	0.00257	CcSEcCtD
Oxymorphone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00107	0.00256	CcSEcCtD
Oxymorphone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00107	0.00256	CcSEcCtD
Oxymorphone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00107	0.00256	CcSEcCtD
Oxymorphone—Vertigo—Prednisone—ankylosing spondylitis	0.00106	0.00254	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—ankylosing spondylitis	0.00106	0.00254	CcSEcCtD
Oxymorphone—Syncope—Prednisone—ankylosing spondylitis	0.00105	0.00253	CcSEcCtD
Oxymorphone—Anorexia—Betamethasone—ankylosing spondylitis	0.00105	0.00252	CcSEcCtD
Oxymorphone—Anorexia—Dexamethasone—ankylosing spondylitis	0.00105	0.00252	CcSEcCtD
Oxymorphone—Urticaria—Prednisolone—ankylosing spondylitis	0.00105	0.00252	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00105	0.00252	CcSEcCtD
Oxymorphone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00105	0.00252	CcSEcCtD
Oxymorphone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00105	0.00251	CcSEcCtD
Oxymorphone—Pain—Triamcinolone—ankylosing spondylitis	0.00104	0.0025	CcSEcCtD
Oxymorphone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00103	0.00248	CcSEcCtD
Oxymorphone—Hypotension—Betamethasone—ankylosing spondylitis	0.00103	0.00247	CcSEcCtD
Oxymorphone—Hypotension—Dexamethasone—ankylosing spondylitis	0.00103	0.00247	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—ankylosing spondylitis	0.00102	0.00246	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00245	CcSEcCtD
Oxymorphone—Convulsion—Prednisone—ankylosing spondylitis	0.00102	0.00245	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00245	CcSEcCtD
Oxymorphone—Hypertension—Prednisone—ankylosing spondylitis	0.00102	0.00244	CcSEcCtD
Oxymorphone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.001	0.00241	CcSEcCtD
Oxymorphone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000999	0.0024	CcSEcCtD
Oxymorphone—Anxiety—Prednisone—ankylosing spondylitis	0.000998	0.0024	CcSEcCtD
Oxymorphone—Insomnia—Betamethasone—ankylosing spondylitis	0.000997	0.0024	CcSEcCtD
Oxymorphone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000997	0.0024	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000995	0.00239	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000991	0.00238	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000989	0.00238	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—ankylosing spondylitis	0.000983	0.00236	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000973	0.00234	CcSEcCtD
Oxymorphone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00097	0.00233	CcSEcCtD
Oxymorphone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00097	0.00233	CcSEcCtD
Oxymorphone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000965	0.00232	CcSEcCtD
Oxymorphone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000963	0.00231	CcSEcCtD
Oxymorphone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00096	0.00231	CcSEcCtD
Oxymorphone—Oedema—Prednisone—ankylosing spondylitis	0.00096	0.00231	CcSEcCtD
Oxymorphone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000958	0.0023	CcSEcCtD
Oxymorphone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000958	0.0023	CcSEcCtD
Oxymorphone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000958	0.0023	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000952	0.00229	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000952	0.00229	CcSEcCtD
Oxymorphone—Fatigue—Betamethasone—ankylosing spondylitis	0.00095	0.00228	CcSEcCtD
Oxymorphone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00095	0.00228	CcSEcCtD
Oxymorphone—Shock—Prednisone—ankylosing spondylitis	0.000945	0.00227	CcSEcCtD
Oxymorphone—Pain—Dexamethasone—ankylosing spondylitis	0.000943	0.00226	CcSEcCtD
Oxymorphone—Pain—Betamethasone—ankylosing spondylitis	0.000943	0.00226	CcSEcCtD
Oxymorphone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000942	0.00226	CcSEcCtD
Oxymorphone—Tachycardia—Prednisone—ankylosing spondylitis	0.000937	0.00225	CcSEcCtD
Oxymorphone—Skin disorder—Prednisone—ankylosing spondylitis	0.000933	0.00224	CcSEcCtD
Oxymorphone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000928	0.00223	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000927	0.00223	CcSEcCtD
Oxymorphone—Anorexia—Prednisone—ankylosing spondylitis	0.000915	0.0022	CcSEcCtD
Oxymorphone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000908	0.00218	CcSEcCtD
Oxymorphone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000908	0.00218	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000901	0.00217	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000901	0.00217	CcSEcCtD
Oxymorphone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000895	0.00215	CcSEcCtD
Oxymorphone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000893	0.00215	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—ankylosing spondylitis	0.000883	0.00212	CcSEcCtD
Oxymorphone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000876	0.0021	CcSEcCtD
Oxymorphone—Urticaria—Betamethasone—ankylosing spondylitis	0.000876	0.0021	CcSEcCtD
Oxymorphone—Dizziness—Prednisolone—ankylosing spondylitis	0.000874	0.0021	CcSEcCtD
Oxymorphone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000872	0.00209	CcSEcCtD
Oxymorphone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000871	0.00209	CcSEcCtD
Oxymorphone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000871	0.00209	CcSEcCtD
Oxymorphone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000871	0.00209	CcSEcCtD
Oxymorphone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000871	0.00209	CcSEcCtD
Oxymorphone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00087	0.00209	CcSEcCtD
Oxymorphone—Insomnia—Prednisone—ankylosing spondylitis	0.000868	0.00209	CcSEcCtD
Oxymorphone—Pruritus—Triamcinolone—ankylosing spondylitis	0.00086	0.00207	CcSEcCtD
Oxymorphone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000858	0.00206	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—ankylosing spondylitis	0.000852	0.00205	CcSEcCtD
Oxymorphone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000845	0.00203	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—ankylosing spondylitis	0.000837	0.00201	CcSEcCtD
Oxymorphone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000835	0.00201	CcSEcCtD
Oxymorphone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000832	0.002	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000831	0.002	CcSEcCtD
Oxymorphone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000829	0.00199	CcSEcCtD
Oxymorphone—Fatigue—Prednisone—ankylosing spondylitis	0.000828	0.00199	CcSEcCtD
Oxymorphone—Headache—Prednisolone—ankylosing spondylitis	0.000828	0.00199	CcSEcCtD
Oxymorphone—Constipation—Prednisone—ankylosing spondylitis	0.000821	0.00197	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—ankylosing spondylitis	0.000809	0.00194	CcSEcCtD
Oxymorphone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000803	0.00193	CcSEcCtD
Oxymorphone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000802	0.00193	CcSEcCtD
Oxymorphone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000791	0.0019	CcSEcCtD
Oxymorphone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000791	0.0019	CcSEcCtD
Oxymorphone—Asthenia—Betamethasone—ankylosing spondylitis	0.000791	0.0019	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000787	0.00189	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000785	0.00189	CcSEcCtD
Oxymorphone—Nausea—Prednisolone—ankylosing spondylitis	0.000785	0.00189	CcSEcCtD
Oxymorphone—Pruritus—Betamethasone—ankylosing spondylitis	0.00078	0.00187	CcSEcCtD
Oxymorphone—Pruritus—Dexamethasone—ankylosing spondylitis	0.00078	0.00187	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000779	0.00187	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000776	0.00186	CcSEcCtD
Oxymorphone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000773	0.00186	CcSEcCtD
Oxymorphone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000771	0.00185	CcSEcCtD
Oxymorphone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000765	0.00184	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—ankylosing spondylitis	0.000765	0.00184	CcSEcCtD
Oxymorphone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000764	0.00183	CcSEcCtD
Oxymorphone—Urticaria—Prednisone—ankylosing spondylitis	0.000763	0.00183	CcSEcCtD
Oxymorphone—Headache—Triamcinolone—ankylosing spondylitis	0.000761	0.00183	CcSEcCtD
Oxymorphone—Headache—Methylprednisolone—ankylosing spondylitis	0.000759	0.00182	CcSEcCtD
Oxymorphone—Abdominal pain—Prednisone—ankylosing spondylitis	0.000759	0.00182	CcSEcCtD
Oxymorphone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000759	0.00182	CcSEcCtD
Oxymorphone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000754	0.00181	CcSEcCtD
Oxymorphone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000754	0.00181	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—ankylosing spondylitis	0.00075	0.0018	CcSEcCtD
Oxymorphone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000729	0.00175	CcSEcCtD
Oxymorphone—Dizziness—Betamethasone—ankylosing spondylitis	0.000729	0.00175	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—ankylosing spondylitis	0.000726	0.00174	CcSEcCtD
Oxymorphone—Nausea—Triamcinolone—ankylosing spondylitis	0.000722	0.00173	CcSEcCtD
Oxymorphone—Nausea—Methylprednisolone—ankylosing spondylitis	0.00072	0.00173	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000715	0.00172	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—ankylosing spondylitis	0.000713	0.00171	CcSEcCtD
Oxymorphone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000707	0.0017	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000706	0.0017	CcSEcCtD
Oxymorphone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000701	0.00168	CcSEcCtD
Oxymorphone—Vomiting—Betamethasone—ankylosing spondylitis	0.000701	0.00168	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000697	0.00168	CcSEcCtD
Oxymorphone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000694	0.00167	CcSEcCtD
Oxymorphone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000694	0.00167	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000693	0.00166	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—ankylosing spondylitis	0.000692	0.00166	CcSEcCtD
Oxymorphone—Headache—Betamethasone—ankylosing spondylitis	0.000691	0.00166	CcSEcCtD
Oxymorphone—Headache—Dexamethasone—ankylosing spondylitis	0.000691	0.00166	CcSEcCtD
Oxymorphone—Asthenia—Prednisone—ankylosing spondylitis	0.000689	0.00165	CcSEcCtD
Oxymorphone—Pain—Methotrexate—ankylosing spondylitis	0.000686	0.00165	CcSEcCtD
Oxymorphone—Pruritus—Prednisone—ankylosing spondylitis	0.000679	0.00163	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000661	0.00159	CcSEcCtD
Oxymorphone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000657	0.00158	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000656	0.00158	CcSEcCtD
Oxymorphone—Nausea—Betamethasone—ankylosing spondylitis	0.000655	0.00157	CcSEcCtD
Oxymorphone—Nausea—Dexamethasone—ankylosing spondylitis	0.000655	0.00157	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—ankylosing spondylitis	0.000637	0.00153	CcSEcCtD
Oxymorphone—Dizziness—Prednisone—ankylosing spondylitis	0.000635	0.00153	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000634	0.00152	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000634	0.00152	CcSEcCtD
Oxymorphone—Vomiting—Prednisone—ankylosing spondylitis	0.00061	0.00147	CcSEcCtD
Oxymorphone—Dermatitis—Prednisone—ankylosing spondylitis	0.000605	0.00145	CcSEcCtD
Oxymorphone—Headache—Prednisone—ankylosing spondylitis	0.000601	0.00145	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000591	0.00142	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—ankylosing spondylitis	0.000576	0.00138	CcSEcCtD
Oxymorphone—Nausea—Prednisone—ankylosing spondylitis	0.00057	0.00137	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—ankylosing spondylitis	0.000568	0.00136	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000549	0.00132	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—ankylosing spondylitis	0.000531	0.00127	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—ankylosing spondylitis	0.00051	0.00123	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000505	0.00121	CcSEcCtD
Oxymorphone—Headache—Methotrexate—ankylosing spondylitis	0.000503	0.00121	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—ankylosing spondylitis	0.000477	0.00115	CcSEcCtD
